Skip to content
Research Article Open access CC BY 3.0

Virulence Markers and Antifungal Susceptibility Profile of Candida glabrata: An Emerging Pathogen

Sachin Deorukhkar, Santosh Saini

Microbiology Research Journal International · pp. 39–49 · Published 5 Oct 2013

10.9734/BMRJ/2014/5806

Abstract

Aims: To study virulence factors and antifungal susceptibility profile of C. glabrata isolated from various clinical specimens. Study Design: A total of 175 C. glabrata spp. isolated from various clinical specimens were included in the study. Place and Duration of Study: Department of Microbiology, Rural Medical College, Pravara Institute of Medical Sciences (PIMS), Loni, Maharashtra, India, between March 2008 to March 2013. Methodology: C. glabrata was identified by sugar assimilation and fermentation tests and colony color on Hichrome Candida agar. HiCandida identification kit supplemented the identification of the isolates. The virulence markers studied were production of extracellular hydrolytic enzymes (phospholipase, proteinase and coagulase), haemolytic activity and biofilm formation. The antifungal susceptibility profile of C. glabrata isolates was determined by Hicomb minimum inhibitory concentration (MIC) test. The antifungal agents used were amphotericin B (range 0.002-32 µg), fluconazole (range 0.016-256 µg), itraconazole (range 0.002-32 µg) and ketoconazole (range 0.002-32 µg). Results: Maximum number of isolates were obtained from blood culture (36%) followed by urine sample (29.7%). ICU stay followed by HIV infection were the main predisposing factors found to be associated with C. glabrata infection. A total of 53 (30.2%) C. glabrata isolates showed phospholipase activity. Proteinase production was seen in 56 (32%) isolates. 48 (27.4%) isolates were coagulase positive. Haemolytic activity was noted in 43 (24.5%) isolates. Most of C. glabrata produced β- type of haemolysis on sheep blood SDA agar. Biofilm forming ability was noted in 68 (38.8%) isolates. Maximum isolates were resistant to fluconazole (46.8%) and ketoconazole (46.8%) followed by itraconazole (45.7%). Amphotericin B resistance was seen in 58 (33.1%) isolates. Conclusion: Once considered as a non pathogenic human commensal, C. glabrata has emerged as an important pathogen in various clinical types of candidiasis. C. glabrata is innately resistant to antifungal drugs and various antifungal mechanisms of the body. Present research data available is not satisfactory to understand the pathogenic and other mechanisms involved in the transition of C. glabrata from nonpathogenic commensal to a potential pathogen. Therefore more research studies are needed to explain pathogenesis, host-pathogen interaction and other survival properties of this emerging pathogen.

Candida glabrata emerging pathogen fluconazole virulence factors.

References (24)

  1. 1 Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis [DOI]
  2. 2 Candida Infections of Medical Devices [DOI]
  3. 3 Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans [DOI]
  4. 4 Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999 [DOI]
  5. 5 Plate method for detection of phospholipase activity inCandida albicans [DOI]
  6. 6 Resistance to Antifungal Agents: Mechanisms and Clinical Impact [DOI]
  7. 7 Invasive fungal infections: a review of epidemiology and management options [DOI]
  8. 8 Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance [DOI]
  9. 9 Biofilm lifestyle of Candida: a mini review [DOI]
  10. 10 Production of a hemolytic factor by Candida albicans [DOI]
  11. 11 Distribution of Candida Species in Different Clinical Samples and Their Virulence: Biofilm Formation, Proteinase and Phospholipase Production: A Study on Hospitalized Patients in Southern India [DOI]
  12. 12 A review of Candida species causing blood stream infection [DOI]
  13. 13 Factors affecting the phospholipase activity ofCandidaspeciesin vitro [DOI]
  14. 14 Serum-proteins as nitrogen source for yeastlike fungi [DOI]
  15. 15 Candida glabrata , an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans [DOI]
  16. 16 In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens [DOI]
  17. 17 Multicenter Brazilian Study of Oral Candida Species Isolated from Aids Patients [DOI]
  18. 18 Non albicans Candida species: its isolation pattern, species distribution, virulence factors and antifungal susceptibility profile [DOI]
  19. 19 Correlation between phospholipase of Candida albicans and resistance to fluconazole [DOI]
  20. 20 FREQUENCY AND ETIOLOGY OF VULVOVAGINAL CANDIDIASIS IN WOMEN REFERRED TO A GYNECOLOGICAL CENTER IN BABOL, IRAN [DOI]
  21. 21 Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital [DOI]
  22. 22 Rapid identification of Candida glabrata in Candida bloodstream infections [DOI]
  23. 23 Candida glabrata Fungemia [DOI]
  24. 24 Electrophoretic Karyotyping and Triazole Susceptibility of Candida glabrata Clinical Isolates [DOI]

Cited by 40

Virulence Attributes of Clinical Candida glabrata (Sensu Stricto) Isolates in the West Region of Cameroon

Claude Nangwat, Thierry Kammalac Ngouana, Aude Ngueguim Dougue, Cyrille Levis Kountchou, Alfred Itor Ekpo, Jean Paul Dzoyem, Christopher Bonglavnyuy Tume · Asian Journal of Research in Infectious Diseases · 2020

Effect of Incubation Temperature and Human Serum on Yeast to Hyphal Morphogenesis in Vaginal Candida albicans and its Correlation to Virulence Markers

Talat A. El-Kersh, Raid A. Alakeel, Abdulaziz H. Alhamidi, Ziab Z. Al-Ahmadey · Microbiology Research Journal International · 2014

Global prevalence and trends of fluconazole resistance in non-albicans Candida species: a systematic review and meta-analysis

Xue-Hua Li, Mohammad Sholeh, Mahya Abedi Moghadam · BMC Infectious Diseases · 2026

ANTIFUNGAL DRUG RESISTANCE PATTERN AMONG BIOFILM PRODUCING STRAINS OF CANDIDA SPECIES ISOLATED FROM BLOODSTREAM INFECTIONS

Nilakshi Borah, Lakshyasri Baishya, Ajanta Sharma · International journal of scientific research · 2022

Non-Candida albicans Candida species: virulence factors and species identification in India

Dharmendra Singh, Rajesh Kumar Verma, S. Sarswat · Current Medical Mycology · 2021

Showing 31 of 40 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

124

Page views

0

PDF downloads

34

Outbound clicks

40

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.